Fundraising Fox
Bitrobius Genetics
2 known investors
Find your way into Bitrobius Genetics
Sign up to see every warm intro you have to Bitrobius Genetics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Bitrobius Genetics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Bitrobius develops gene therapy technologies, specifically the Gentrafix platform, leveraging microbial molecular biology and genetic engineering. The company serves therapeutic applications in areas including neurodegeneration and drug discovery.
Founders & leadership
DR
Dr Rocky CranenburghFounder
Investors · 2
Future Planet Capitallisted by Future Planet CapitalLondon
How we know: Future Planet Capital's portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Bitrobius Genetics do?
- Bitrobius develops gene therapy technologies, specifically the Gentrafix platform, leveraging microbial molecular biology and genetic engineering. The company serves therapeutic applications in areas including neurodegeneration and drug discovery.
- Who founded Bitrobius Genetics?
- Bitrobius Genetics was founded by Dr Rocky Cranenburgh.
- Who are Bitrobius Genetics's investors?
- Bitrobius Genetics's investors include Future Planet Capital, UK Innovation & Science Seed Fund.